Home >Current Issue

Volume: 9, Issue: 8, August, 2019
DOI: 10.7324/JAPS.2019.90812

Research Article

Development and evaluation of liquid oral controlled release systems for Losartan potassium

Marwa A. Amer1, Ebtessam A. Essa1, Ahmed A. Donia2, Gamal M. El Maghraby1

  Author Affiliations


Losartan potassium is a water soluble antihypertensive agent with short half-life. Controlling its release will improve patient compliance. The benefit will be extended for geriatric patients if the developed system was liquid. The objective of this work was to develop controlled release oral liquid losartan potassium. This employed a combination of in situ gelation and coating drug particles with pH-dependent polymer (Eudragit® L100). Solid dispersion (SD) prepared at 1:1, 1:1.5, and 1:2 drug : polymer ratios, respectively. Sodium alginate solution was loaded with either pure drug or SD, in presence and absence of 1% w/v chitosan. These systems were evaluated for the drug release using continuous pH variation study. Alginate formulation with pure drug underwent in situ gelation in the gastric conditions but lost the gelling strength in the intestinal phase with burst drug release. Loading the formulation with SD resulted in controlled drug release both in the gastric and intestinal phases. Increasing eudragit concentration in SD decreased the drug released with total release efficiency of 62.1%, 53.0%, and 41.7%. Incorporation of chitosan at reduced further drug release rate reaching 21% at the higher eudragit concentration. The study provided the formulator with a range of oral liquid formulations for controlled release of losartan potassium.


Losartan potassium, in situ gelling, controlled release, Eudragit® L100, sodium alginate.

Citation: Amer MA, Essa EA, Donia AA, El Maghraby GM. Development and evaluation of liquid oral controlled release systems for Losartan potassium. J Appl Pharm Sci, 2019; 9(08):086–093.

Copyright: The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Becherán-Marón L, Peniche C, Argüelles-Monal W. Study of the interpolyelectrolyte reaction between chitosan and alginate: influence of alginate composition and chitosan molecular weight. Int J Biol Macromol, 2004; 34(1-2):127-33. https://doi.org/10.1016/j.ijbiomac.2004.03.010

Cetin M, Atila A, Kadioglu Y. Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium. AAPS PharmSciTech, 2010; 11(3):1250-6. https://doi.org/10.1208/s12249-010-9489-6

El Maghraby GM, Elsisi AE, Elmeshad GA. Development of liquid oral sustained release formulations of nateglinide: in vitro and in vivo evaluation. J Drug Deliv Sci Technol, 2015; 29:70-7. https://doi.org/10.1016/j.jddst.2015.06.011

El Maghraby GM, Elzayat EM, Alanazi FK. Investigation of in situ gelling alginate formulations as a sustained release vehicle for co-precipitates of dextromethrophan and Eudragit S 100. Acta Pharm, 2014; 64(1):29-44. https://doi.org/10.2478/acph-2014-0002

El Maghraby GM, Elzayat EM, Alanazi FK. Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan and eudrgit S100. Drug Dev Ind Pharm, 2012; 38(8):971-8. https://doi.org/10.3109/03639045.2011.634811

Emami J, Varshosaz J, Ahmadi F. Preparation and evaluation of a liquid sustained-release drug delivery system for theophylline using spray-drying technique. Res Pharm Sci, 2008; 2(1):1-11.

Essa EA, Diwakat M. Enhancement of simvastatin dissolution via surface solid dispersion; effect of carriers and wetting agents. J Appl Pharm Sci, 2015; 5(1):054-3.

Essa E, Negm M, Zin Eldin E, El Maghraby G. Fast disintegrating tablets of amiodarone for intra-oral administration. J Appl Pharm Sci, 2017; 7(01):064-72. https://doi.org/10.7324/JAPS.2017.70109

Gollapudi R, Javvaji H, Tadikonda RR, Arpineni V. Formulation and evaluation of sustained release matrix tablets of Losartan potassium. Res J Pharm Biol Chem Sci, 2014; 3(2):526-34.

Itoh K, Kubo W, Fujiwara M, Watanabe H, Miyazaki S, Attwood D. The influence of gastric acidity and taste masking agent on in situ gelling pectin formulations for oral sustained delivery of acetaminophen. Biol Pharm Bull, 2006; 29(2):343-7. https://doi.org/10.1248/bpb.29.343

Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol, 1975; 27(1):48-9. https://doi.org/10.1111/j.2042-7158.1975.tb09378.x

Khattab WM, Gad S, El-Sayed MM, Ghorab MM. Simple controlled release delivery system for an anti-hypertensive drug via buccal route. Br J Pharm Res, 2014; 4(10):1174-95. https://doi.org/10.9734/BJPR/2014/9789

Kim KH, Frank MJ, Henderson NL. Application of differential scanning calorimetry to the study of solid drug dispersions. J Pharm Sci, 1985; 74(3):283-9. https://doi.org/10.1002/jps.2600740312

Kubo W, Miyazaki S, Attwood D. Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations. Int J Pharm, 2003; 258(1-2):55-64. https://doi.org/10.1016/S0378-5173(03)00163-7

Lee BJ, Cui JH, Kim TW, Heo MY, Kim CK. Biphasic release characteristics of dual drug-loaded alginate beads. Arch Pharm Res, 1998; 21:645-50. https://doi.org/10.1007/BF02976751

Miyazaki S, Kubo W, Attwood D. Oral sustained delivery of theophylline using in-situ gelation of sodium alginate. J Control Release, 2000; 67(2-3):275-80. https://doi.org/10.1016/S0168-3659(00)00214-5

Murata Y, Miyamoto E, Kawashima S. Additive effect of chondroitin sulfate and chitosan on drug release from calcium-induced alginate gel beads. J Control Release, 1996; 38(2-3):101-8. https://doi.org/10.1016/0168-3659(95)00098-4

Niraj VK, Srivastava N, Singh T, Gupta U. Sustained and controlled drug delivery system-As a part of modified release dosage form. Int J Pharma Sci, 2013; 2(5):586-601.

Nirmal HB, Bakliwal SR, Pawar SP. In-situ gel: new trends in controlled and sustained drug delivery system. Int J PharmTech Res, 2010; 2(2):1398-408.

Ribeiro AJ, Silva C, Ferreira D, Veiga F. Chitosan-reinforced alginate microspheres obtained through the emulsification/internal gelation technique. Eur J Pharm Sci, 2005; 25(1):31-40. https://doi.org/10.1016/j.ejps.2005.01.016

Sarwar S, Hossain MS. Development and evaluation of sustained release losartan potassium matrix tablet using kollidon SR as release retardant. Brazilian J Pharm Sci, 2012; 48(4):621-8. https://doi.org/10.1590/S1984-82502012000400005

Shah KP, Chafetz L. Use of sparingly soluble salts to prepare oral sustained release suspensions. Int J Pharm, 1994; 109(3):271-81. https://doi.org/10.1016/0378-5173(94)90389-1

Sharma M, Sharma V, Panda AK, Majumdar DK. Development of enteric submicron particle formulation of papain for oral delivery. Int J Nanomed, 2011; 6:2097-111. https://doi.org/10.2147/IJN.S23985

Sica DA, Gehr TW, Ghosh S. Clinical pharmacokinetics of losartan. Clin Pharmacokinet, 2005; 44(8):797-814. https://doi.org/10.2165/00003088-200544080-00003

Velmurufan S, Srinivas P. Formulation and in vitro evaluation of losartan potassium mucoadhesive tablets. Asian J Pharm Clin Res, 2013; 6(3):125-30.

Vohra DD, Pagi KS, Rajesh KS. Losartan potassium loaded sustained release matrix tablets: influence of various hydrophilic and hydrophobic polymers on drug release behaviour. J Pharm Bioallied Sci, 2012;4(5):S79-80. https://doi.org/10.4103/0975-7406.94147

Wang L, Khor E, Lim LY. Chitosan-alginate-CaCl(2) system for membrane coat application. J Pharm Sci, 2001; 90(8):1134-42. https://doi.org/10.1002/jps.1067

Article Metrics

Similar Articles

Interaction of Losartan potassium with the micelles of Triton X 100
Laila Abdel-Fattah, Amira El-Kosasy, Lobna Abdel-Aziz, Mariam Gaied

Microchip for Drug Delivery System : A Review
Ravindra Pal Singh, Nasit sarju, Anil Sharma, Stuti Gupta Singh, Khunt Sanket